Irritable Bowel Syndrome: AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Constipation (2022)

This guideline summary provides supportive information to patients and healthcare providers about the risks and benefits of pharmaceutical treatment for irritable bowel syndrome (IBS) with a prevalence of constipation (IBS-C).
 

Download PDF Version